Small-business payment apps don’t require additional hardware to accept payments from customers. There’s also often no monthly fee. 250+ small-business products reviewed and rated by our team of ...

In addition to the Android poker apps recommended in the video, we’ve considered our own time grinding games on iOS poker apps to put together a list of five real money poker apps. Crucially, these ...

Casino apps have your favorite games just a few taps away. You can play from anywhere on an optimized interface with all the perks and bonuses you’d expect, including fast loading, touchscreen ...

GameSpot may get a commission from retail offers. This month, Netflix debuted the new animated series, Splinter Cell: Deathwatch, which brings back Tom Clancy's Sam Fisher, the lead character of ...

On this page, you'll find detailed reviews of the best sports betting apps and betting sites in the industry. We've examined DraftKings, FanDuel, BetMGM, Caesars, Fanatics, and bet365, evaluating ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Why this is important: This marks Netflix’s biggest push to turn its platform from purely passive entertainment to an interactive hub. By moving games into the TV space, the company is doubling down ...

Graham Kates is an investigative reporter covering criminal justice, privacy issues and information security for CBS News Digital. Contact Graham at [email protected] or [email protected] ...

GameSpot may get a commission from retail offers. There’s a scene in Splinter Cell: Deathwatch--Netflix's animated adaptation of Ubisoft's stealth game series--where Sam Fisher casually walks in front ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.